30 December 2011

Johnson & Johnson Refuses To License Three HIV Drugs To Medicines Patent Pool; Invites Patent Override

By their very nature, drug patents can create monopolies that allow prices to be kept artificially high. In other domains that may be simply an annoyance or inconvenience, but in the world of medicines, it can be a matter of life or death for those unable to afford those inflated prices. 

On Techdirt.

No comments: